SKI Market

A+| A| A-|

Indian Indices

Sensex

74,532.96 325.72
( 0.44%)

Global Indices

Nasdaq

45,612.20 -430.24
(-0.93%)

Dow Jones

6,526.68 -100.81
(-1.52%)

Hang Seng

53,297.18 -1,942.22
(-3.52%)

Nikkei 225

9,927.54 -135.96
(-1.35%)

Forex

USD-INR

93.13 0.41
(0.44%)

EUR-INR

107.17 0.41
(0.39%)

GBP-INR

124.14 0.56
(0.45%)

JPY-INR

0.59 0.00
(0.73%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

ANG Lifesciences India Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

540694

INE236W01016

49.9768362

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

28.6

EPS(TTM)

Face Value()

Div & Yield %

Back

Dhansafal Finserve reports standalone net loss of Rs 0.10 crore in the September 2025 quarter

Nov 15,2025

Net Loss of Dhansafal Finserve reported to Rs 0.10 crore in the quarter ended September 2025 as against net loss of Rs 0.30 crore during the previous quarter ended September 2024. Sales rose 452.00% to Rs 2.76 crore in the quarter ended September 2025 as against Rs 0.50 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	2.76	0.50	452
OPM %	14.86	-102.00	-
PBDT	0.13	-0.43	LP
PBT	-0.08	-0.43	81
NP	-0.10	-0.30	67

74,532.96 325.72 ( 0.44%)

45,612.20 -430.24 (-0.93%)

6,526.68 -100.81 (-1.52%)

53,297.18 -1,942.22 (-3.52%)

9,927.54 -135.96 (-1.35%)

93.13 0.41 (0.44%)

107.17 0.41 (0.39%)

124.14 0.56 (0.45%)

0.59 0.00 (0.73%)